Polivy Interactions
There are 412 drugs known to interact with Polivy (polatuzumab vedotin), along with 5 disease interactions. Of the total drug interactions, 79 are major, 320 are moderate, and 13 are minor.
- View all 412 medications that may interact with Polivy
- View Polivy disease interactions (5)
Most frequently checked interactions
View interaction reports for Polivy (polatuzumab vedotin) and the medicines listed below.
- abacavir
- Adderall XR (amphetamine / dextroamphetamine)
- Adriamycin (doxorubicin)
- aluminum hydroxide / magnesium trisilicate
- ascorbic acid
- Bendeka (bendamustine)
- Blenoxane (bleomycin)
- chlordiazepoxide
- Cytoxan Lyophilized (cyclophosphamide)
- Depakote Sprinkles (divalproex sodium)
- Dibenzyline (phenoxybenzamine)
- diltiazem / enalapril
- Elelyso (taliglucerase alfa)
- Emtriva (emtricitabine)
- Epivir-HBV (lamivudine)
- Epogen (epoetin alfa)
- esomeprazole
- ethionamide
- Fintepla (fenfluramine)
- fosinopril
- Givlaari (givosiran)
- Hyperhep B (hepatitis b immune globulin)
- InnoPran XL (propranolol)
- Intron A (interferon alfa-2b)
- Invirase (saquinavir)
- Isentress HD (raltegravir)
- itraconazole
- Klonopin (clonazepam)
- lactulose
- Lanoxicaps (digoxin)
Polivy disease interactions
There are 5 disease interactions with Polivy (polatuzumab vedotin) which include:
Report options
More about Polivy (polatuzumab vedotin)
- Polivy consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Monjuvi
Monjuvi is used for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) or follicular ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Kymriah
Kymriah is used to treat acute lymphoblastic leukemia (ALL) that is relapsing or refractory in ...
Yescarta
Yescarta is a CAR T-cell treatment used to treat relapsed or refractory large B-cell lymphoma ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Zynlonta
Zynlonta (loncastuximab tesirine) is used to treat relapsed or refractory diffuse large B-cell ...
Columvi
Columvi is used to treat certain types of diffuse large B-cell lymphoma (DLBCL) or large B-cell ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.